Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
ROE: Returns Declining
Trending lower, above historical average, strong compound growth.
Left:
||||
Return on equity
Latest
-144.96%
↑ 25% above average
Average (9y)
-194.27%
Historical baseline
Range
High:-46.50%
Low:-516.99%
CAGR
+13.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -144.96% | -18.5% |
| 2023 | -122.28% | +46.2% |
| 2022 | -227.48% | -159.8% |
| 2021 | -87.57% | +63.2% |
| 2020 | -237.78% | +54.0% |
| 2019 | -516.99% | -137.2% |
| 2018 | -217.94% | -34.0% |
| 2017 | -162.70% | +8.8% |
| 2016 | -178.44% | -283.7% |
| 2015 | -46.50% | - |